France · Series D startup

Who invested in Onxeo

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$30Mraised across 2 rounds since 2003, from 2 sources

$17MSeries C$13MSeries D
Latest round
Series D, $13MMay 2005
Biggest round
$17MSeries C · May 2003
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20042005
$17MSeries C$13MSeries D
First round
Series C, $17M
May 2003
Biggest round
$17M
Series C · May 2003
Between rounds
2 years
from the last two

The rounds

  1. May 2005
    Series D$13M1 new4 returning

    From a historical funding record

  2. May 2003
    Series C$17M4 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Seventure PartnersVC firm2rounds
XAngeVC firm2rounds
Auriga PartnersVC firm2rounds
Capricorn PartnersVC firm2rounds
Groupe SiparexVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Onxeo

Who invested in Onxeo?

Onxeo's investors include Seventure Partners, XAnge, Auriga Partners, Capricorn Partners and Groupe Siparex.

How much has Onxeo raised?

Onxeo has raised $30M across 2 rounds since 2003.

When did Onxeo last raise?

Onxeo's most recent round was a Series D of $13M in May 2005.

What was Onxeo's biggest round?

Onxeo's largest round on record is $17M (Series C), in May 2003.

Who backed Onxeo first?

Onxeo's first round on record, in May 2003, was backed by Seventure Partners, XAnge and Auriga Partners and 1 others.

What stage is Onxeo at?

Onxeo's latest named round is a Series D, in May 2005.

Where is Onxeo based?

Onxeo is based in France.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.